Literature DB >> 24550249

Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).

Murielle Mary-Krause, Sophie Grabar, Laurence Lièvre, Sophie Abgrall, Eric Billaud, François Boué, Laurence Boyer, André Cabié, Laurent Cotte, Pierre De Truchis, Xavier Duval, Claudine Duvivier, Patricia Enel, Jacques Gasnault, Catherine Gaud, Jacques Gilquin, Marguerite Guiguet, Christine Katlama, Marie-Aude Khuong-Josses, Jean-Marc Lacombe, Sylvie Lang, Anne-Sophie Lascaux, Odile Launay, Aba Mahamat, Sophie Matheron, Jean-Luc Meynard, Juliette Pavie, Fabrice Pilorgé, Lionel Piroth, Isabelle Poizot-Martin, Valérie Potard, Christian Pradier, Jacques Reynes, Elisabeth Rouveix, Hana Selinger-Leneman, Anne Simon, Pierre Tattevin, Hervé Tissot-Dupont, Jean-Paul Viard, Nathalie Viget, Dominique Costagliola.   

Abstract

The French Hospital Database on HIV (FHDH) is a hospital-based multicentre open cohort with inclusions ongoing since 1989. The research objectives focus mainly on mid- and long-term clinical outcomes and therapeutic strategies, as well as severe AIDS and non-AIDS morbidities, and public health issues relative to HIV infection. FHDH also serves to describe HIV-infected patients receiving hospital care in France. FHDH includes data on more than 120,000 HIV-infected patients from 70 French general or university hospitals distributed throughout France. Patients are eligible for inclusion if they are infected by HIV-1 or HIV-2 and give their written informed consent. Standardized variables are collected at each outpatient visit or hospital admission during which a new clinical manifestation is diagnosed, a new treatment is prescribed or a change in biological markers is noted, and/or at least every 6 months. Since its inception, variables collected in FHDH include demographic characteristics, HIV-related biological markers, the date and type of AIDS and non AIDS-defining events, antiretroviral treatments and the date and causes of death, as reported in the medical records. Since 2005, data have also been collected on: co-infection with hepatitis B or C virus; alcohol and tobacco use; and non HIV-related biomarkers. Anyone can submit a research project by completing a standardized form available on the FHDH website (http://www.ccde.fr/_fold/fl-1385734776-429.pdf) or from the corresponding author, describing the context and objectives of the study. All projects are reviewed by the scientific committee.
© The Author 2014; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Entities:  

Keywords:  AIDS; FHDH; HIV; antiretroviral treatment; cohort; comorbidities

Mesh:

Year:  2014        PMID: 24550249     DOI: 10.1093/ije/dyu002

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  15 in total

1.  Tobacco use and HIV symptom severity in Chinese people living with HIV.

Authors:  Wei-Ti Chen; Chengshi Shiu; Joyce P Yang; Myo Mie Mie Tun; Lin Zhang; Kerong Wang; Li-Chen Chen; Myo Nyein Aung; Hongzhou Lu; Hongxin Zhao
Journal:  AIDS Care       Date:  2019-05-22

2.  Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort.

Authors:  Sylvie Lang; Jean-Marc Lacombe; Murielle Mary-Krause; Marialuisa Partisani; Frédéric Bidegain; Laurent Cotte; Elisabeth Aslangul; Antoine Chéret; Franck Boccara; Jean-Luc Meynard; Christian Pradier; Pierre-Marie Roger; Pierre Tattevin; Dominique Costagliola; Jean-Michel Molina
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

3.  Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.

Authors:  Valérie Potard; Jacques Reynes; Tristan Ferry; Céline Aubin; Laurent Finkielsztejn; Yazdan Yazdanpanah; Dominique Costagliola
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

4.  Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.

Authors:  Laure-Amélie de Monteynard; Rosemary Dray-Spira; Pierre de Truchis; Sophie Grabar; Odile Launay; Jean-Luc Meynard; Marie-Aude Khuong-Josses; Jacques Gilquin; David Rey; Anne Simon; Juliette Pavie; Aba Mahamat; Sophie Matheron; Dominique Costagliola; Sophie Abgrall
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

5.  Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination.

Authors:  Clovis Lusivika-Nzinga; Hana Selinger-Leneman; Sophie Grabar; Dominique Costagliola; Fabrice Carrat
Journal:  BMC Med Res Methodol       Date:  2017-12-04       Impact factor: 4.615

6.  Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status.

Authors:  Aliou Baldé; Sylvie Lang; Aline Wagner; Jean Ferrières; Michèle Montaye; Pierre Tattevin; Laurent Cotte; Elisabeth Aslangul; Frédéric Bidégain; Antoine Chéret; Murielle Mary-Krause; Jean-Luc Meynard; Jean-Michel Molina; Marialuisa Partisani; Pierre-Marie Roger; Franck Boccara; Dominique Costagliola
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

7.  Critical importance of long-term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004-2011 in the FHDH-ANRS CO4 cohort.

Authors:  Blandine Denis; Marguerite Guiguet; Nathalie de Castro; Frédéric Mechaï; Matthieu Revest; Aba Mahamat; Giovanna Melica Gregoire; Olivier Lortholary; Dominique Costagliola
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

8.  Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4.

Authors:  Sophie Grabar; Hana Selinger-Leneman; Sophie Abgrall; Gilles Pialoux; Laurence Weiss; Dominique Costagliola
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

9.  Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens.

Authors:  Valérie Potard; Cécile Goujard; Marc Antoine Valantin; Jean Marc Lacombe; Rima Lahoulou; Arnaud Chéret; Pierre Marie Girard; Dominique Costagliola
Journal:  BMC Infect Dis       Date:  2018-07-11       Impact factor: 3.090

10.  Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.

Authors:  Laure-Amélie de Monteynard; Sophie Matheron; Sophie Grabar; Pierre de Truchis; Jacques Gilquin; Juliette Pavie; Odile Launay; Jean-Luc Meynard; Marie-Aude Khuong-Josses; David Rey; Aba Mahamat; Rosemarie Dray-Spira; Anne Simon; Dominique Costagliola; Sophie Abgrall
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.